- Previous Close
2.9000 - Open
2.9200 - Bid 2.9500 x 100
- Ask 3.0100 x 100
- Day's Range
2.7100 - 3.0500 - 52 Week Range
1.8100 - 8.5000 - Volume
1,347,390 - Avg. Volume
589,093 - Market Cap (intraday)
103.772M - Beta (5Y Monthly) 0.98
- PE Ratio (TTM)
-- - EPS (TTM)
-1.7900 - Earnings Date Mar 3, 2025 - Mar 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.33
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
908devices.comRecent News: MASS
View MorePerformance Overview: MASS
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MASS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MASS
View MoreValuation Measures
Market Cap
103.77M
Enterprise Value
39.27M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.81
Price/Book (mrq)
0.79
Enterprise Value/Revenue
0.71
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-109.11%
Return on Assets (ttm)
-15.56%
Return on Equity (ttm)
-40.00%
Revenue (ttm)
55.16M
Net Income Avi to Common (ttm)
-60.19M
Diluted EPS (ttm)
-1.7900
Balance Sheet and Cash Flow
Total Cash (mrq)
71.69M
Total Debt/Equity (mrq)
5.48%
Levered Free Cash Flow (ttm)
-18.16M